File:NLC416-08jh011505-26116 拜耳新藥大全.pdf

From Wikimedia Commons, the free media repository
Jump to navigation Jump to search
Go to page
next page →
next page →
next page →

Original file(1,239 × 1,754 pixels, file size: 13.86 MB, MIME type: application/pdf, 530 pages)

Captions

Captions

Add a one-line explanation of what this file represents

Summary[edit]

拜耳新藥大全   (Wikidata search (Cirrus search) Wikidata query (SPARQL)  Create new Wikidata item based on this file)
Author
[拜耳藥品無限公司編]
image of artwork listed in title parameter on this page
Title
拜耳新藥大全
Publisher
[拜耳藥品無限公司]
Description

此書為拜耳大藥廠(Bayer)生產的160餘種西藥商品錄。並附拜耳新藥大全目次及分類用藥表

目錄
各種良藥
亞保心
阿保羅的
辯阿保羅的
阿即多耳配符新
阿特靈
阿非舵藥皂
阿搿靈 梯烏新
亞爾敗近
安夫脫羅水
阿那雖信
安癩露
阿立斯妥清
阿司匹芬寧
阿司匹靈
阿的平
安穩酊
培他生
百福臨
布妥倫
康復之餅
康已隆
康泰
卡布勒
嘉色鉍
利膽弗拉文
雪克諾林
咖啡蜜拿
複方咖啡蜜拿
康普樂
康脫拉近軟膏
考立芬
克利西佛
特太肥
代未剛
杜羅登
伊拉純 鐵伊拉純
愛兒杜方
益利特靈
恩托同
安樂根
哀司麻地
優規寧
伊惟本
鈉伊惟本
凡食泰
福銻
加當
格樂維妥
庫阿可斯
海而密妥
益多納
赫破弗辛
伊可賴
應必妥
因蘇林
一試滌淨
局卡潑拉
乍鐵紅
育維寧
來克諾
拜耳乳黃素
癆必用
盧蜜拿
路脫侖
孟納妥爾
美盧白靈
滅疥
莫而旦拿
新安立生
新斯銻波霜
羅瓦而精
雞納羅瓦而精
拿佛阿色羅
奴佛客因
奧拍泰純
臥褥定
歐力新
保妥酊
旁弗拉文
本妥卡因
本妥卡因'l'
北里多
福眠錠
拜耳磷酸水泥
百司母困
百樂朋
補奴郎
普蜜拿 普蜜拿粒吞
百浪多息
普泰哥
霹藍米藤
奎諾百司母困 百司母困復劑
拉西特靈
逆伏靈
雷佛奴耳
雷佛奴耳粒吞
雷佛奴耳眼藥膏
立復侖
灑乍錠
灑利汞
色而伐納
賽雷丁
雪亞能
所拉純
所買妥司
斯砒螺剌脫
斯必路色
蘇潑拉來寧
梯烏密拿
拜耳健身素
肚納芬
托拿福賜芬
多能體
脫呂帕弗拉文
土門奴耳
溫敦
佛里耳
維婁那耳 鈉維婁那耳
維剛妥
復康
成石凝
藥特靈
奶酪藥特靈注射液
賜福露
灑爾佛散製品
灑爾佛散
妙婉灑爾佛散
新灑爾佛散
新銀灑爾佛散
聖露灑爾佛散
生物製品
貝靈藥特靈化膿菌混合漿苗
貝靈霍亂漿苗
霍亂保安使
貝靈可烈藥特靈
貝靈白喉抗毒素
貝靈白喉預防漿苗
貝靈痢疾血清
貝靈抗丹毒鏈狀球菌血清
貝靈氣性壞疽血清
果乃金
貝靈白濁球菌混合漿苗
貝靈白濁藥特靈
貝靈腦膜炎血清
貝靈藥特靈補腦注射液
貝靈通常馬血清
握姆納丁
貝靈腹膜炎血清
貝靈百日咳漿苗
貝靈百日咳混合漿苗
貝靈鼠疫備血清
貝靈鼠疫漿苗
貝靈肺炎球菌血清
貝靈產褥熱煉狀球菌血清
貝靈猩紅熱血清
斯太法
貝靈藥特靈葡萄狀球菌漿苗
貝靈煉球菌血清精
貝靈藥特靈煉球菌漿苗
貝靈破傷風抗毒素
貝靈四合漿苗
癬瘡清毒漿
「郭后」結核菌素
無蛋白質結核菌素
結核血清漿苗
貝靈傷寒血清
貝靈傷寒漿苗
窒扶了
雪露而
萬鈕而

Language Chinese
Publication date [1947]
Source
institution QS:P195,Q732353
(民國時期文獻 民國圖書)
主題
InfoField
藥品
中圖分類
InfoField
R97
載體形態
InfoField
486頁

Licensing[edit]

This image is in the public domain because it is a mere mechanical scan or photocopy of a public domain original, or – from the available evidence – is so similar to such a scan or photocopy that no copyright protection can be expected to arise. The original itself is in the public domain for the following reason:
Public domain
This image is now in the public domain in China because its term of copyright has expired.

According to copyright laws of the People's Republic of China (with legal jurisdiction in the mainland only, excluding Hong Kong and Macao), amended November 11, 2020, Works of legal persons or organizations without legal personality, or service works, or audiovisual works, enter the public domain 50 years after they were first published, or if unpublished 50 years from creation. For photography works of natural persons whose copyright protection period expires before June 1, 2021 belong to the public domain. All other works of natural persons enter the public domain 50 years after the death of the creator.
According to copyright laws of Republic of China (currently with jurisdiction in Taiwan, Penghu, Kinmen, Matsu, etc.), all photographs and cinematographic works, and all works whose copyright holder is a juristic person, enter the public domain 50 years after they were first published, or if unpublished 50 years from creation, and all other applicable works enter the public domain 50 years after the death of the creator.

Important note: Works of foreign (non-U.S.) origin must be out of copyright or freely licensed in both their home country and the United States in order to be accepted on Commons. Works of Chinese origin that have entered the public domain in the U.S. due to certain circumstances (such as publication in noncompliance with U.S. copyright formalities) may have had their U.S. copyright restored under the Uruguay Round Agreements Act (URAA) if the work was under copyright in its country of origin on the date that the URAA took effect in that country. (For the People's Republic of China, the URAA took effect on January 1, 1996. For the Republic of China (ROC), the URAA took effect on January 1, 2002.[1])
To uploader: Please provide where the image was first published and who created it or held its copyright.

You must also include a United States public domain tag to indicate why this work is in the public domain in the United States. Note that this work might not be in the public domain in countries that do not apply the rule of the shorter term and have copyright terms longer than life of the author plus 50 years. In particular, Mexico is 100 years, Jamaica is 95 years, Colombia is 80 years, Guatemala and Samoa are 75 years, Switzerland and the United States are 70 years, and Venezuela is 60 years.


čeština  Deutsch  English  português  română  slovenščina  Tagalog  Tiếng Việt  македонски  русский  മലയാളം  ไทย  한국어  日本語  简体中文‎  繁體中文  +/−



This tag is designed for use where there may be a need to assert that any enhancements (eg brightness, contrast, colour-matching, sharpening) are in themselves insufficiently creative to generate a new copyright. It can be used where it is unknown whether any enhancements have been made, as well as when the enhancements are clear but insufficient. For known raw unenhanced scans you can use an appropriate {{PD-old}} tag instead. For usage, see Commons:When to use the PD-scan tag.


Note: This tag applies to scans and photocopies only. For photographs of public domain originals taken from afar, {{PD-Art}} may be applicable. See Commons:When to use the PD-Art tag.

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeThumbnailDimensionsUserComment
current18:09, 21 April 2023Thumbnail for version as of 18:09, 21 April 20231,239 × 1,754, 530 pages (13.86 MB)PencakeBot (talk | contribs)Upload 拜耳新藥大全 (1/1) by [拜耳藥品無限公司編] (batch task; nlc:data_416,08jh011505,26116; 民國圖書-PD2022.2; 拜耳新藥大全)

The following page uses this file:

Metadata